PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Esketamine hydrochloride - Depression

PAD Profile : Esketamine hydrochloride - Depression

Keywords :
Treatment resistant
Brand Names Include :
Spravato

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Important
Formulations :
  • Not Specified
Important Information :
Subject to NICE TA854
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has confirmed a NON-FORMULARY traffic light status for esketamine for treating major depressive disorder in adults at imminent risk of suicide.

This decision is in view of the NICE terminated Technology Appraisal for esketamine for this indication

Associated BNF Codes

04. Central Nervous System
04.03.04. Other antidepressant drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More